 Connection
Hitoshi Irabu to Female
This is a "connection" page, showing publications Hitoshi Irabu has written about Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.258 |
|
|
|
-
Irabu H, Ohara A, Nakamura A, Narazaki H, Hayashi Y, Yamasaki Y, Iwata N, Ohshima S, Nishiyama S, Nakagishi Y, Fukuhara D, Ishida H, Goto M, Hashimoto K, Yasuoka R, Nozawa T, Miyamae T, Umebayashi H, Mori M, Shimizu M. Validation of the 2019 EULAR/ACR classification criteria and clinical characteristics of childhood-onset Japanese patients with systemic lupus erythematosus. Mod Rheumatol. 2026 Mar 05; 36(2):239-245.
Score: 0.033
-
Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Ohta K, Yachie A. Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy. J Immunol Res. 2020; 2020:4284379.
Score: 0.022
-
Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Tasaki Y, Ohta K, Yachie A, Wada T. Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Schönlein purpura nephritis. Pediatr Res. 2021 02; 89(3):667-672.
Score: 0.022
-
Irabu H, Shimizu M, Kaneko S, Inoue N, Mizuta M, Nakagishi Y, Yachie A. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy. Pediatr Res. 2020 12; 88(6):934-939.
Score: 0.022
-
Shimizu M, Tada N, Irabu H, Murakoshi M, Udagawa T. Successful treatment of intractable edema with Goreisan in severe lupus nephritis with nephrotic syndrome: a case report. CEN Case Rep. 2026 Feb 05; 15(2):45.
Score: 0.008
-
Kaneko S, Mizuta M, Hatano M, Shimbo A, Irabu H, Yatabe R, Akamine K, Sugita Y, Hashimoto K, Yamasaki Y, Nakagishi Y, Mori M, Takagi M, Shimizu M. Distinct cytokine signature in juvenile dermatomyositis: linking myositis-specific antibodies and clinical manifestations. Cytokine. 2026 Jan; 197:157070.
Score: 0.008
-
Shimbo A, Kaneko S, Irabu H, Akutsu Y, Hayashi Y, Mouri M, Yamazaki S, Mori M, Shimizu M. Efficacy of hydroxychloroquine treatment for the skin manifestations of juvenile dermatomyositis. Mod Rheumatol Case Rep. 2025 07 25; 9(2).
Score: 0.008
-
Hayashi Y, Hatano M, Kaneko S, Shimbo A, Irabu H, Mori M, Shimizu M. Macrophage activation syndrome associated with neonatal lupus erythematosus. Lupus. 2025 Aug; 34(9):978-981.
Score: 0.008
-
Shmizu M, Kaneko S, Shimbo A, Hatano M, Miyaoka F, Irabu H, Akutsu Y, Hayashi Y, Akamine K, Mori M. Anifrolumab for refractory cutaneous lupus lesions in pediatric systemic lupus erythematosus. Lupus. 2025 Apr; 34(5):533-536.
Score: 0.008
-
Eguchi G, Murakoshi M, Miyaoka F, Shimbo A, Irabu H, Kanamori T, Udagawa T, Morio T, Shimizu M. Acute tubulointerstitial nephritis following coronavirus disease 2019 mRNA vaccination: a pediatric case report. CEN Case Rep. 2025 Apr; 14(2):261-265.
Score: 0.008
-
Kaneko S, Shimbo A, Irabu H, Mizuta M, Nakagishi Y, Iwata N, Yokoyama K, Yasumura J, Akamine K, Ueno K, Fujita S, Watanabe K, Watanabe S, Nishikawa H, Fujimura J, Mori M, Shimizu M. Serum interleukin-18 levels can improve the diagnostic performance of the PRINTO and ILAR criteria for systemic juvenile idiopathic arthritis. Cytokine. 2024 10; 182:156719.
Score: 0.007
-
Kaneko S, Shimbo A, Irabu H, Hatano M, Takasawa K, Kamiya T, Akamine K, Tanaka T, Minato T, Ono M, Yokoyama K, Arisaka A, Yasumi T, Ueno K, Fujita S, Tanaka Y, Hayashi D, Nishikawa H, Fujita Y, Yuza Y, Mori M, Morio T, Shimizu M. Pathogenic role and diagnostic utility of interferon-a in histiocytic necrotizing lymphadenitis. Clin Immunol. 2024 Sep; 266:110324.
Score: 0.007
-
Yamazaki S, Shimizu M, Yakabe A, Inage E, Jimbo K, Suzuki M, Miyaoka F, Kaneko S, Irabu H, Shimbo A, Ohtomo Y, Mori M, Morio T, Shimizu T. Successful treatment with tofacitinib for anti-melanoma differentiation-associated gene 5 antibody-positive juvenile dermatomyositis: case reports and review of the literature. Immunol Med. 2024 Jun; 47(2):110-117.
Score: 0.007
-
Hatano M, Kaneko S, Irabu H, Shimizu M. Successful treatment of Sweet syndrome complicated by Behcet disease with adalimumab. Pediatr Int. 2024 Jan-Dec; 66(1):e15815.
Score: 0.007
-
Kanda S, Shimbo A, Nakamura Y, Matsuno R, Kaneko S, Irabu H, Kaneko K, Shimizu M. Anti-Ku antibody-positive systemic sclerosis and idiopathic inflammatory myopathies overlap syndrome in children: a report of two cases and a review of the literature. Clin Rheumatol. 2023 Dec; 42(12):3411-3417.
Score: 0.007
-
Kaneko S, Shimizu M, Shimbo A, Irabu H, Yokoyama K, Furuno K, Tanaka T, Ueno K, Fujita S, Iwata N, Fujimura J, Akamine K, Mizuta M, Nakagishi Y, Minato T, Watanabe K, Kobayashi A, Endo T, Tabata K, Mori M, Morio T. Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickers. Cytokine. 2023 09; 169:156280.
Score: 0.007
-
Kaneko S, Shimizu M, Shimbo A, Irabu H, Yamazaki S, Kanamori T, Udagawa T, Morio T, Mori M. A girl with hearing loss, dizziness, hypertension, and pyelonephritis with ureteral edema: Answers. Pediatr Nephrol. 2022 12; 37(12):3059-3061.
Score: 0.006
-
Kaneko S, Shimizu M, Shimbo A, Irabu H, Yamazaki S, Kanamori T, Udagawa T, Morio T, Mori M. A girl with hearing loss, dizziness, hypertension, and pyelonephritis with ureteral edema: Questions. Pediatr Nephrol. 2022 12; 37(12):3057-3058.
Score: 0.006
-
Shimizu M, Inoue N, Mizuta M, Irabu H, Okajima M, Honda Y, Nihira H, Izawa K, Yachie A, Wada T. Successful treatment of spondyloenchondrodysplasia with baricitinib. Rheumatology (Oxford). 2021 02 01; 60(2):e44-e46.
Score: 0.006
-
Mizuta M, Shimizu M, Irabu H, Usami M, Inoue N, Nakagishi Y, Wada T, Yachie A. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children. Rheumatology (Oxford). 2021 01 05; 60(1):231-238.
Score: 0.006
-
Sakumura N, Irabu H, Inoue N, Mizuta M, Shimizu M. Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab. Rheumatology (Oxford). 2020 01 01; 59(1):252-254.
Score: 0.005
-
Kaneko S, Shimizu M, Irabu H, Yachie A. Acute generalized exanthematous pustulosis in a child with fasciitis. Pediatr Int. 2019 Sep; 61(9):938.
Score: 0.005
-
Usami M, Shimizu M, Mizuta M, Inoue N, Irabu H, Sakumura N, Nakagishi Y, Yachie A. Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus. Clin Immunol. 2019 11; 208:108255.
Score: 0.005
-
Takakura M, Shimizu M, Irabu H, Sakumura N, Inoue N, Mizuta M, Nakagishi Y, Yachie A. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Clin Immunol. 2019 11; 208:108252.
Score: 0.005
-
Shimizu M, Irabu H, Kaneda H, Ohta K, Nozu K. Familial focal segmental glomerulosclerosis with PLCE1 mutation in siblings. Pediatr Int. 2019 Jul; 61(7):726-727.
Score: 0.005
-
Jinkawa A, Shimizu M, Nishida K, Kaneko S, Usami M, Sakumura N, Irabu H, Takakuwa M, Inoue N, Mizuta M, Ikawa Y, Fujita S, Yachie A. Cytokine profile of macrophage activation syndrome associated with Kawasaki disease. Cytokine. 2019 07; 119:52-56.
Score: 0.005
-
Fujita S, Nishida K, Irabu H, Nakagawa R, Futatani T, Igarashi N, Usuda K, Nagata Y, Ohno S, Horie M, Hatasaki K. Catecholaminergic polymorphic ventricular tachycardia managed as orthostatic dysregulation and epilepsy in 11- and 15-year-old sisters. Pediatr Int. 2018 Nov; 60(11):998-1001.
Score: 0.005
-
Shimizu M, Inoue N, Kuroda M, Irabu H, Takakura M, Kaneda H, Sugimoto N, Ohta K, Yachie A. Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Clin Exp Nephrol. 2017 Dec; 21(6):1083-1087.
Score: 0.004
-
Goto Y, Nishimura R, Nohara A, Mase S, Fujiki T, Irabu H, Kuroda R, Araki R, Ikawa Y, Maeba H, Yachie A. Minimal contribution of severe hypertriglyceridemia in L-asparaginase-associated pancreatitis developed in a child with acute lymphocytic leukemia. Rinsho Ketsueki. 2016 08; 57(8):994-8.
Score: 0.004
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|